Albumedix, now part of Sartorius, is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our recombinant human albumin products.
We believe in empowering excellence to enable advanced therapies and unstable drug candidates reach patients worldwide. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide.
Headquartered in Nottingham, England with more than 100 people all committed to improving patient quality of life.
We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.